Neptune Technologies & Bioresources Inc Profit Margin 2009-2019 | NEPT
Current and historical gross margin, operating margin and net profit margin for Neptune Technologies & Bioresources Inc (NEPT) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Neptune Technologies & Bioresources Inc net profit margin as of June 30, 2019 is -107.62%.
| Neptune Technologies & Bioresources Inc Annual Profit Margins |
|---|
| Neptune Technologies & Bioresources Inc Quarterly Profit Margins |
|---|
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.327B | $0.018B |
| Neptune Wellness Solutions Inc. operates as a nutrition supplement company. It develops and produces cannabis products, marine oils, seed oils and pet supplements. Neptune Wellness Solutions Inc., formerly known as Neptune Technologies & Bioressources Inc., is headquartered in Laval, Canada. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $145.598B | 26.57 |
| Medtronic (MDT) | Ireland | $145.585B | 20.43 |
| Stryker (SYK) | United States | $80.642B | 27.89 |
| Boston Scientific (BSX) | United States | $53.170B | 25.79 |
| Baxter (BAX) | United States | $44.852B | 27.20 |
| EssilorLuxottica Societe Anonyme (ESLOY) | France | $32.725B | 0.00 |
| Zimmer Biomet Holdings (ZBH) | United States | $28.438B | 18.20 |
| Coloplast (CLPBY) | Denmark | $25.747B | 41.10 |
| Lonza Group Ag (LZAGY) | Switzerland | $25.481B | 0.00 |
| Terumo (TRUMY) | Japan | $24.495B | 30.57 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $20.928B | 0.00 |
| ResMed (RMD) | United States | $18.924B | 36.06 |
| Sunny Optical Technology (SNPTF) | China | $16.014B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $10.234B | 54.86 |
| Insulet (PODD) | United States | $9.431B | 558.86 |
| Perrigo (PRGO) | Ireland | $7.400B | 13.63 |
| Canopy Growth (CGC) | Canada | $7.222B | 0.00 |
| Hill-Rom Holdings (HRC) | United States | $6.830B | 20.36 |
| Haemonetics (HAE) | United States | $6.455B | 48.71 |
| William Demant Holdings (WILYY) | Denmark | $5.988B | 0.00 |
| GN STORE NORD (GNNDY) | Denmark | $5.344B | 27.61 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $4.296B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $4.002B | 0.00 |
| GW Pharmaceuticals (GWPH) | United Kingdom | $3.680B | 0.00 |
| Neogen (NEOG) | United States | $3.490B | 58.40 |
| NuVasive (NUVA) | United States | $3.398B | 27.09 |
| ICU Medical (ICUI) | United States | $3.237B | 21.00 |
| Hutchison China MediTech (HCM) | Hong Kong, SAR China | $2.634B | 0.00 |
| Quidel (QDEL) | United States | $2.510B | 24.93 |
| Agios Pharmaceuticals (AGIO) | United States | $1.982B | 0.00 |
| National Vision Holdings (EYE) | United States | $1.877B | 40.51 |
| Cardiovascular Systems (CSII) | United States | $1.670B | 0.00 |
| Aphria (APHA) | $1.242B | 0.00 | |
| VAREX IMAGING (VREX) | United States | $1.124B | 25.90 |
| AtriCure (ATRC) | United States | $1.059B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.867B | 14.10 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.854B | 21.78 |
| NanoString Technologies (NSTG) | United States | $0.787B | 0.00 |
| Omeros (OMER) | United States | $0.759B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $0.734B | 19.29 |
| PetIQ (PETQ) | United States | $0.725B | 17.13 |
| LeMaitre Vascular (LMAT) | United States | $0.689B | 40.82 |
| Cerus (CERS) | United States | $0.624B | 0.00 |
| Surmodics (SRDX) | United States | $0.621B | 118.00 |
| MacroGenics (MGNX) | United States | $0.560B | 0.00 |
| Quanterix (QTRX) | United States | $0.548B | 0.00 |
| TG Therapeutics (TGTX) | United States | $0.530B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.523B | 24.23 |
| Owens & Minor (OMI) | United States | $0.459B | 13.76 |
| Meridian Bioscience (VIVO) | United States | $0.427B | 13.32 |
| Utah Medical Products (UTMD) | United States | $0.354B | 25.91 |
| Zynex (ZYXI) | United States | $0.346B | 36.76 |
| BioLife Solutions (BLFS) | United States | $0.339B | 104.19 |
| Bovie Medical (APYX) | United States | $0.234B | 0.00 |
| United Health Products (UEEC) | United States | $0.208B | 0.00 |
| Vapotherm (VAPO) | United States | $0.177B | 0.00 |
| Repro-Med Systems (REPR) | United States | $0.158B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.153B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.147B | 0.00 |
| Female Health (VERU) | United States | $0.138B | 0.00 |
| Fonar (FONR) | United States | $0.133B | 9.32 |
| InfuSystems Holdings (INFU) | United States | $0.127B | 0.00 |
| Liberty Health Sciences (LHSIF) | Canada | $0.104B | 0.00 |
| Chembio Diagnostics (CEMI) | United States | $0.097B | 0.00 |
| Chimerix (CMRX) | United States | $0.088B | 0.00 |
| Nephros (NEPH) | United States | $0.087B | 0.00 |
| United-Guardian (UG) | United States | $0.084B | 19.82 |
| MTech Acquisition (KERN) | United States | $0.063B | 0.00 |
| MRI Interventions (MRIC) | United States | $0.058B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.053B | 0.00 |
| ImmuCell (ICCC) | United States | $0.040B | 0.00 |
| Surface Oncology (SURF) | United States | $0.039B | 0.00 |
| Senestech (SNES) | United States | $0.023B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.020B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.018B | 0.00 |
| Conatus Pharmaceuticals (CNAT) | United States | $0.013B | 0.00 |
| Myomo (MYO) | United States | $0.010B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.010B | 0.00 |
| Valeritas Holdings (VLRX) | United States | $0.007B | 0.00 |
| Akers Biosciences Inc (AKER) | United States | $0.005B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.003B | 0.00 |
